| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
inquiry@bocsci.com |
6-Aza-2'-deoxyuridine manufacturers
|
| | 6-Aza-2'-deoxyuridine Basic information |
| Product Name: | 6-Aza-2'-deoxyuridine | | Synonyms: | 2'-Deoxy-6-azauridine;2-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazine-3,5-dione;1,2,4-Triazine-3,5(2H,4H)-dione, 2-(2-deoxy-β-D-erythro-pentofuranosyl)-;2-(2-Deoxy-β-D-erythro -pentofuranosyl)-1,2,4-
triazine-3,5(2H ,4H )-dione;6-Aza-2'-deoxyuridine;2’-Deoxy-6-azauridine | | CAS: | 20500-29-2 | | MF: | C8H11N3O5 | | MW: | 229.19 | | EINECS: | | | Product Categories: | | | Mol File: | 20500-29-2.mol |  |
| | 6-Aza-2'-deoxyuridine Chemical Properties |
| Melting point | 182 °C(Solv: ethanol (64-17-5)) | | density | 1.90±0.1 g/cm3(Predicted) | | pka | 7.88±0.20(Predicted) |
| | 6-Aza-2'-deoxyuridine Usage And Synthesis |
| Uses | 6-Aza-2'-deoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 6-Aza-2'-deoxyuridine Preparation Products And Raw materials |
|